FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome
FAST-funded researchers at Texas A&M created the first-ever pig model of Angelman syndrome using CRISPR, offering a new platform that more closely mirrors human brain biology.
FAST announces establishment of associated drug development accelerator AS²Bio
FAST launches AS²Bio, a drug development accelerator building an integrated ecosystem to advance gene therapy, CRISPR, and stem cell programs for Angelman syndrome and beyond.